9341 Stock Overview
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
GENOVA, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,260.00 |
| 52 Week High | JP¥2,478.00 |
| 52 Week Low | JP¥1,168.00 |
| Beta | 0 |
| 1 Month Change | -9.22% |
| 3 Month Change | -24.23% |
| 1 Year Change | 0.72% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -27.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9341 | JP Healthcare Services | JP Market | |
|---|---|---|---|
| 7D | 2.6% | 4.4% | 2.2% |
| 1Y | 0.7% | -37.0% | 27.7% |
Return vs Industry: 9341 exceeded the JP Healthcare Services industry which returned -35.7% over the past year.
Return vs Market: 9341 underperformed the JP Market which returned 28.3% over the past year.
Price Volatility
| 9341 volatility | |
|---|---|
| 9341 Average Weekly Movement | 6.6% |
| Healthcare Services Industry Average Movement | 6.5% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 9341's share price has been volatile over the past 3 months.
Volatility Over Time: 9341's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 358 | Tomoki Hirase | www.genova.co.jp |
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital.
GENOVA, Inc. Fundamentals Summary
| 9341 fundamental statistics | |
|---|---|
| Market cap | JP¥22.42b |
| Earnings (TTM) | JP¥1.57b |
| Revenue (TTM) | JP¥8.13b |
14.3x
P/E Ratio2.8x
P/S RatioIs 9341 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9341 income statement (TTM) | |
|---|---|
| Revenue | JP¥8.13b |
| Cost of Revenue | JP¥2.01b |
| Gross Profit | JP¥6.11b |
| Other Expenses | JP¥4.55b |
| Earnings | JP¥1.57b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | 88.01 |
| Gross Margin | 75.22% |
| Net Profit Margin | 19.27% |
| Debt/Equity Ratio | 1.8% |
How did 9341 perform over the long term?
See historical performance and comparison